Radiotheranostics Market : Growth, Segments, Share And Global Forecasts 2023-2032 | Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Radiotheranostics Global Market Report 2023 identifies increasing prevalence of cancer as the major driver for the Radiotheranostics market's growth in the forecast period. Radiotheranostics medicines are commonly employed in cancer to offer the ultimate notion of customized medicine by using paired diagnostic and therapeutic radionuclide probes for the selective and targeted detection and treatment of specific (typically cancer) cells, each of which is suited to the patient's underlying condition to enhance treatment efficiency and better clinical output.

The global radiotheranostics market is expected to grow from $6.60 billion in 2022 to $7.57 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global radiotheranostics is expected to reach $12.85 billion in 2027 at a CAGR of 14.1%.

Download Free Sample Of Radiotheranostics Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=12270&type=smp

Major competitors in the Radiotheranostics market are Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Boston Scientific Corporation, Terumo Corporation, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., and Navidea Biopharmaceuticals Inc.

A key trend in the Radiotheranostics market includes product innovations. Significant companies are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in May 2023, Advanced Cyclotron Systems Inc., a Canada-based company that supplies and services cyclotrons predominantly used for producing medical isotopes, introduced TR-ALPHA for producing alpha-emitting radioisotopes to treat cancer.

Read More On The Global Radiotheranostics Market Report Here:
https://www.thebusinessresearchcompany.com/report/radiotheranostics-global-market-report

The Radiotheranostics market is segmented -

By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fludeoxyglucose-18F, Yttrium-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioisotopes

By Approach: Targeted Therapeutic, Targeted Diagnostic

By Application: Oncology, Non-Oncology

By End-Users: Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End-Users

By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Asia-Pacific was the largest region in the Radiotheranostics market.

The Business Research Company's "Global Radiotheranostics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Radiotheranostics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12270

The Table Of Content For The Radiotheranostics Market Include:
1. Executive Summary
2. Radiotheranostics Market Characteristics
3. Radiotheranostics Market Trends And Strategies
4. Radiotheranostics Market - Macro Economic Scenario
5. Global Radiotheranostics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
……
32. Global Radiotheranostics Market Competitive Benchmarking
33. Global Radiotheranostics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Radiotheranostics Market
35. Radiotheranostics Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.